The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
News|Articles|April 28, 2014
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-05-07-2014
- Volume 10
- Issue 5
Sartorius Stedim Biotech Acquires Majority Stake in AllPure Technologies
Author(s)Pharmaceutical Technology Editors
Sartorius Stedim Biotech's acquisition of AllPure Technologies will extends its portfolio for single-use bioprocessing.
Advertisement
Source:
Articles in this issue
over 12 years ago
Using eClinical Systems for Supply-Chain Managementover 12 years ago
FDA and Industry Take Action for a More Secure Drug Supply Chainover 12 years ago
Packaging Becomes Enabler for Biopharmaceuticalsover 12 years ago
Azzur Group and BioSPEQ Announce Mergerover 12 years ago
Eli Lilly Launches Second Education Program for Medical Studentsover 12 years ago
Global Instability Impacts Brazil's Pharma Marketover 12 years ago
US Biopharma Worries About Losing Lead in Innovationover 12 years ago
Outsourcing Remains Strong In Traditional AreasAdvertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement